
Darwin Private Equity makes first exit with Maxinutrition
Darwin Private Equity, founded in 2007 by former executives from Permira and CVC, has made its first exit with the £162m sale of sports nutrition company Maxinutrition to GlaxoSmithKline.
If approved by the OFT, Darwin says the sale will represent a successful conclusion to an investment that was made exactly three years ago. Darwin Private Equity acquired the business in a £75m secondary buyout from Piper Private Equity. The latter, Maximuscle's first private equity backer. itself generated a 10x return on its £3.2m commitment to the funding of the firm's initial BIMBO in 2004.
The unquote" team is currently researching this transaction. In-depth deal information for subscribers will follow shortly.
If you have any information regarding this transaction, please contact Julian Longhurst on +44 20 7004 7449 or julian.longhurst@incisivemedia.com
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater